# A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling

## Metadata
**Authors:** Maria T Di Martino, Mariamena Arbitrio, Pietro H Guzzi, Emanuela Leone, Francesco Baudi, Eugenio Piro, Tullia Prantera, Iole Cucinotto, Teresa Calimeri, Marco Rossi, Pierangelo Veltri, Mario Cannataro, Pierosandro Tagliaferri, Pierfrancesco Tassone
**Journal:** British Journal of Haematology
**Date:** 2011 Apr 26
**DOI:** [10.1111/j.1365-2141.2011.08622.x](https://doi.org/10.1111/j.1365-2141.2011.08622.x)
**PMID:** 21517810
**PMCID:** PMC3638364
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638364/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC3638364/pdf/bjh0154-0529.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC3638364/pdf/bjh0154-0529.pdf)

## Acknowledgments

This work was partially supported by AIRC (Associazione Italiana per la Ricerca sul cancro) (P.T. project 2007–2009), Milan, and PRIN (P.T. 2007–2009), Italy.

## Author contributions

M.T.D., PS.T. and PF.T. designed the study and performed data interpretation; M.T.D. wrote the manuscript; M.T.D and M.A. generated datasets. M.T.D. provided statistical analysis and generated figures; P.H.G., P.V. and M.C. performed data mining; E.P., T.P., I.C., T.C. and M.R. provided blood samples and clinical data; E.L. and F.B. performed sequence analysis; PS.T. and PF.T. reviewed the manuscript.

## Disclosures

The authors declare no conflicts of interest to disclose.

## References

1. Ackert-Bicknell CL, Demissie S, Marín de Evsikova C, Hsu YH, DeMambro VE, Karasik D, Cupples LA, Ordovas JM, Tucker KL, Cho K, Canalis E, Paigen B, Churchill GA, Forejt J, Beamer WG, Ferrari S, Bouxsein ML, Kiel DP, Rosen CJ. PPARG by dietary fat interaction influences bone mass in mice and humans. Journal of Bone and Mineral Research. 2008;23:1398–1408. doi: 10.1359/JBMR.080419.  [DOI](https://doi.org/10.1359/JBMR.080419) | [PMC free article](/articles/PMC2683155/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18707223/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Bone%20and%20Mineral%20Research&title=PPARG%20by%20dietary%20fat%20interaction%20influences%20bone%20mass%20in%20mice%20and%20humans&author=CL%20Ackert-Bicknell&author=S%20Demissie&author=C%20Mar%C3%ADn%20de%20Evsikova&author=YH%20Hsu&author=VE%20DeMambro&volume=23&publication_year=2008&pages=1398-1408&pmid=18707223&doi=10.1359/JBMR.080419&)

2. Dallongeville J, Iribarren C, Ferrières J, Lyon L, Evans A, Go AS, Arveiler D, Fortmann SP, Ducimetière P, Hlatky MA, Amouyel P, Southwick A, Quertermous T, Meirhaeghe A. Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease. PPAR Research. 2009;2009:11. doi: 10.1155/2009/543746. doi: 10.1155/2009/543746.  [DOI](https://doi.org/10.1155/2009/543746) | [DOI](https://doi.org/10.1155/2009/543746) | [PMC free article](/articles/PMC2792957/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/20016803/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=PPAR%20Research&title=Peroxisome%20proliferator-activated%20receptor%20gamma%20polymorphisms%20and%20coronary%20heart%20disease&author=J%20Dallongeville&author=C%20Iribarren&author=J%20Ferri%C3%A8res&author=L%20Lyon&author=A%20Evans&volume=2009&publication_year=2009&pages=11&pmid=20016803&doi=10.1155/2009/543746&)

3. Deeken J. The Affymetrix DMET platform and pharmacogenetics in drug development. Current Opinion in Molecular Therapeutics. 2009;11:260–268.  [PubMed](https://pubmed.ncbi.nlm.nih.gov/19479659/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Current%20Opinion%20in%20Molecular%20Therapeutics&title=The%20Affymetrix%20DMET%20platform%20and%20pharmacogenetics%20in%20drug%20development&author=J%20Deeken&volume=11&publication_year=2009&pages=260-268&pmid=19479659&)

4. Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. Journal of Cancer Research and Clinical Oncology. 2010;136:1117–1124. doi: 10.1007/s00432-010-0907-7.  [DOI](https://doi.org/10.1007/s00432-010-0907-7) | [PMC free article](/articles/PMC11828172/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/20508948/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cancer%20Research%20and%20Clinical%20Oncology&title=Bisphosphonate-induced%20osteonecrosis%20of%20the%20jaw:%20a%20review%20of%202,400%20patient%20cases&author=O%20Filleul&author=E%20Crompot&author=S%20Saussez&volume=136&publication_year=2010&pages=1117-1124&pmid=20508948&doi=10.1007/s00432-010-0907-7&)

5. Garcia-Bates TM, Bernstein SH, Phipps RP. Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clinical Cancer Research. 2008;14:6414–6425. doi: 10.1158/1078-0432.CCR-08-0457.  [DOI](https://doi.org/10.1158/1078-0432.CCR-08-0457) | [PMC free article](/articles/PMC2756795/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18927280/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&title=Peroxisome%20proliferator-activated%20receptor%20gamma%20overexpression%20suppresses%20growth%20and%20induces%20apoptosis%20in%20human%20multiple%20myeloma%20cells&author=TM%20Garcia-Bates&author=SH%20Bernstein&author=RP%20Phipps&volume=14&publication_year=2008&pages=6414-6425&pmid=18927280&doi=10.1158/1078-0432.CCR-08-0457&)

6. Kim TH, Hong JM, Park EK, Kim SY. Peroxisome proliferator-activated receptor-gamma gene polymorphisms are not associated with osteonecrosis of the femoral head in the Korean population. Molecules and Cells. 2007;24:388–393.  [PubMed](https://pubmed.ncbi.nlm.nih.gov/18182855/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Molecules%20and%20Cells&title=Peroxisome%20proliferator-activated%20receptor-gamma%20gene%20polymorphisms%20are%20not%20associated%20with%20osteonecrosis%20of%20the%20femoral%20head%20in%20the%20Korean%20population&author=TH%20Kim&author=JM%20Hong&author=EK%20Park&author=SY%20Kim&volume=24&publication_year=2007&pages=388-393&pmid=18182855&)

7. Rosen ED, Spiegelman BM. PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry. 2001;276:37731–37734. doi: 10.1074/jbc.R100034200.  [DOI](https://doi.org/10.1074/jbc.R100034200) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11459852/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&title=PPARgamma%20:%20a%20nuclear%20regulator%20of%20metabolism,%20differentiation,%20and%20cell%20growth&author=ED%20Rosen&author=BM%20Spiegelman&volume=276&publication_year=2001&pages=37731-37734&pmid=11459852&doi=10.1074/jbc.R100034200&)

8. Sarasquete ME, García-Sanz R, Marín L, Alcoceba M, Chillón MC, Balanzategui A, Santamaria C, Rosiñol L, de la Rubia J, Hernandez MT, Garcia-Navarro I, Lahuerta JJ, González M, San Miguel JF. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood. 2008;112:2709–2712. doi: 10.1182/blood-2008-04-147884.  [DOI](https://doi.org/10.1182/blood-2008-04-147884) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18594024/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&title=Bisphosphonate-related%20osteonecrosis%20of%20the%20jaw%20is%20associated%20with%20polymorphisms%20of%20the%20cytochrome%20P450%20CYP2C8%20in%20multiple%20myeloma:%20a%20genome-wide%20single%20nucleotide%20polymorphism%20analysis&author=ME%20Sarasquete&author=R%20Garc%C3%ADa-Sanz&author=L%20Mar%C3%ADn&author=M%20Alcoceba&author=MC%20Chill%C3%B3n&volume=112&publication_year=2008&pages=2709-2712&pmid=18594024&doi=10.1182/blood-2008-04-147884&)

9. Vannucchi AM, Ficarra G, Antonioli E, Bosi A. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. British Journal of Haematology. 2005;128:738. doi: 10.1111/j.1365-2141.2005.05382.x.  [DOI](https://doi.org/10.1111/j.1365-2141.2005.05382.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15755276/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Haematology&title=Osteonecrosis%20of%20the%20jaw%20associated%20with%20zoledronate%20therapy%20in%20a%20patient%20with%20multiple%20myeloma&author=AM%20Vannucchi&author=G%20Ficarra&author=E%20Antonioli&author=A%20Bosi&volume=128&publication_year=2005&pages=738&pmid=15755276&doi=10.1111/j.1365-2141.2005.05382.x&)

10. Wang LH, Yang XY, Zhang X, Huang J, Hou J, Li J, Xiong H, Mihalic K, Zhu H, Xiao W, Farrar WL. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. Immunity. 2004;20:205–218. doi: 10.1016/s1074-7613(04)00030-5.  [DOI](https://doi.org/10.1016/s1074-7613(04)00030-5) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/14975242/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Immunity&title=Transcriptional%20inactivation%20of%20STAT3%20by%20PPARgamma%20suppresses%20IL-6-responsive%20multiple%20myeloma%20cells&author=LH%20Wang&author=XY%20Yang&author=X%20Zhang&author=J%20Huang&author=J%20Hou&volume=20&publication_year=2004&pages=205-218&pmid=14975242&doi=10.1016/s1074-7613(04)00030-5&)
